Nrc Health (NRC) Current Deferred Revenue (2010 - 2026)

Nrc Health (NRC) has 17 years of Current Deferred Revenue data on file, last reported at $17.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 10.87% year-over-year to $17.2 million; the trailing twelve-month figure through Mar 2026 stood at $17.2 million (up 10.87% YoY), and the FY2025 full-year result was $16.2 million, up 2.63% from the prior year.
• Current Deferred Revenue improved to $17.2 million in Q1 2026, from $16.2 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $17.8 million in Q3 2025 to a low of $14.5 million in Q2 2024.
• A 5-year average of $16.0 million and a median of $15.8 million in 2024 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue dropped 11.71% in 2022 and rose 10.87% in 2026, its largest moves.
• Tracing NRC's Current Deferred Revenue over 5 years: stood at $15.2 million in 2022, then slipped by 2.4% to $14.8 million in 2023, then climbed by 6.42% to $15.8 million in 2024, then advanced by 2.63% to $16.2 million in 2025, then gained by 6.12% to $17.2 million in 2026.
• Business Quant data shows NRC's Current Deferred Revenue at $17.2 million in Q1 2026, $16.2 million in Q4 2025, and $17.8 million in Q3 2025.